Antisense epidermal growth factor receptor transfection impairs the proliferative ability of human rhabdomyosarcoma cells

Cancer Research

Volumn 56, Issue 17, 1996, Pages 3898-3901

  De Giovanni, Carla ^a   Landuzzi, Lorena ^a,b   Frabetti, Flavia ^a   Nicoletti, Giordano ^a,b   Griffoni, Cristiana ^a   Rossi, Ilaria ^a,d   Mazzotti, Maria ^c   Scotto, Luigi ^c   Nanni, Patrizia ^a   Lollini, Pier Luigi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b IST Biotechnology Satellite Unit   (Italy)

^c DIBIT HS Raffaele   (Italy)

^d Assoc Italiana per la Ric sul C

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; NEOMYCIN;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; DNA TRANSFECTION; FETAL CALF SERUM; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PLASMID; PRIORITY JOURNAL; RHABDOMYOSARCOMA;

ANIMALS; BASE SEQUENCE; CATTLE; CELL DIFFERENTIATION; CELL DIVISION; DNA, COMPLEMENTARY; HUMANS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RHABDOMYOSARCOMA; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 9444244426     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Dickman, P. S., Tsokos, M., and Triche, T. J. Biology of rhabdomyosarcoma: cell culture, xenografts, and animal models. In: H. M. Maurer, F B. Ruymann, and C Pochedly (eds.), Rhabdomyosarcoma and Related Tumors in Children and Adolescents, pp. 49-88. Boca Raton, FL: CRC Press, 1991.
2. El-Badry, O M., Minniti, C , Kohn, E. C., Houghton, P. J., Daughaday, W. H., and Helman, L. J. Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors. Cell Growth & Differ., 1: 325-331, 1990.
3. Minniti, C P., Kohn, E. C , Grubb, J. H., Sly, W S., Youngman, O., Muller, H. L., Rosenfeld, R. G , and Helman, L. J. The insulin-like growth factor II (IGF-II)/ mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cells. J. Biol. Chem., 267: 9000-9004, 1992.
4. De Giovanni, C , Melani, C., Nanni, P , Landuzzi, L., Nicoletti, G , Frabetti, F , Griffom, C., Colombo, M. P , and Lollini, P-L Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suramin. Br. J. Cancer, 72. 1224-1229, 1995.
5. Schweigerer, L., Neufeld, G., Mergia, A., Abraham, J. A., Fiddes, J. C , and Gospodarowicz, D. Basic fibroblast growth factor in human rhabdomyosarcoma cells: implications for the proliferation and neovascularization of myoblast-derived tumors. Proc. Natl. Acad. Sci. USA, 84: 842-846, 1987.
6. Minniti, C. P., Tsokos, M., Newton, W. A., Jr., and Helman, L. J. Specific expression of insulin-like growth factor-II in rhabdomyosarcoma tumor cells Am. J. Clin. Pathol., 101: 198-203, 1994.
7. Flonni, J. R., and Magri, K. A. Effects of growth factors on myogenic differentiation. Am J. Physiol., 256: C701-C711, 1989.
8. Olson, E. N. Interplay between proliferation and differentiation within the myogenic lineage. Dev. Biol., 154: 261-272, 1992
9. Kalebic, T., Tsokos, M , and Helman, L J In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34cdc2. Cancer Res., 54: 5531-5534, 1994.
10. Shapiro, D. N., Jones, B. G., Shapiro, L H., Dias, P., and Houghton, P. J. Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J. Clin. Invest., 94: 1235-1242, 1994.
11. De Giovanni, C., Lollini, P-L., Dolcetti, R., Landuzzi, L , Nicoletti. G , D'Andrea, E., Scotlandi, K , and Nanni, P. Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells. Br J. Cancer, 67: 674-679, 1993.
12. Moroni, M. C., Willingham, M C., and Beguinot, L. EGF-R antisense RNA blocks expression of the epidermal growth factor receptor and suppresses the transforming phenotype of a human carcinoma cell line. J Biol Chem , 267: 2714-2722, 1992.
13. Ullrich, A., Coussens, L., Hayflick, J S., Dull, T. J., Gray, A , Tam, A W., Lee, J., Yarden, Y., Libermann, T. A., Schlessinger, J., Dawnward, J., Mayes, E L. V , Whittles, N., Waterfield, M. D., and Seeburg, P. H. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells Nature (Lond.), 309: 418-425, 1984
14. Sugawa, N , Ekstrand, A J., James, C. D , and Collins, V P Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc Natl Acad Sci. USA, 87: 8602-8606, 1990.
15. Lollini, P-L., De Giovanni, C , Del Re, B , Landuzzi, L., Nicoletti, G., Prodt, G., Scotlandi, K , and Nanni, P Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs. Cancer Res , 49: 3631-3636, 1989
16. Nanni, P., Schiaffino, S., De Giovanni, G., Nicoletti, G., Prodi, G., Del Re, B., Eusebi, V., Ceccarelli, C , Saggin, L., and Lollini, P-L. RMZ: a new cell line from a human alveolar rhabdomyosarcoma: in vitro expression of embryonic myosin. Br. J. Cancer, 54: 1009-1014, 1986.
17. Squire, J., and Weksberg, R. Genomic imprinting in tumors. Semin. Cancer Biol., 7: 41-47, 1996.
18. Zhan, S., Shapiro, D. N , and Helman, L. J Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcnma. J. Clin. Invest , 94: 445-448, 1994.
19. Breillout, F , Antoine, E., Lascaux, V., Rolland, Y., and Poupon, M-F. Promotion of micrometastasis proliferation in a rat rhabdomyosarcoma model by epidermal growth factor. J. Natl. Cancer Inst., 81, 702-705, 1989
20. St. Clair, J. A , Meyer-Demarest, S D , and Ham, R. G. Improved medium with EGF and BSA for differentiated human skeletal muscle cells. Muscle Nerve, 15: 774-779, 1992
21. Resnicoff, M., Coppola, D., Sell, C., Rubin, R , Ferrone, S., and Baserga, R. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res., 54: 4848-4850, 1994.
22. Long, L., Rubin, R., Baserga, R., and Brodt, P. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor. Cancer Res., 55: 1006-1009, 1995
23. Wu, J-X., and Adamson, E. D. Inhibition of differentiation in P19 embryonal carcinoma cells by the expression of vectors encoding truncated or antisense EGF receptor. Dev Biol., 159: 208-222, 1993.
24. Rajagopal, S., Huang, S , Moskal, T. L., Lee, B-N., El-Naggar, A. K., and Chakrabarty, S Epidermal growth factor expression in human colon and colon carcinomas: anti-sense epidermal growth factor receptor RNA down-regulates the proliferation of human colon cancer cells. Int. J. Cancer, 62: 661-667, 1995
25. Madsen, M W., Lykkesfeldt, A. E , Laursen, I., Nielsen, K V., and Briand, P. Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-α, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirements. Cancer Res., 52: 1210-1217, 1992
26. Soler, C., Alvarez, C V., Beguinot, L., and Carpenter, G Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites. Oncogene, 9: 2207-2215, 1994.
27. Coppola, D., Ferber, A., Miura, M , Sell, C., D'Ambrosio, C., Rubin, R., and Baserga, R. A functional insulin-like growth factor 1 is required for the mitogeninc and transforming activities of the epidermal growth factor receptor Mol. Cell. Biol , 14 4588-4595, 1994.
28. Steller, M A., Delgado, C. H., and Zou, Z. Insulin-like growth factor II mediates epidermal growth factor-induced mitogenesis in cervical cancer cells Proc. Natl. Acad Sci. USA, 92: 11970-11974, 1995.
29. Kelvin, D. J., Simard, G., and Connolly, J. A. FGF and EGF act synergistically to induce proliferation in BC3H1 myoblasts. J. Cell. Physiol., 138, 267-272, 1989.